glp-1 glp-2 glp-3 agonists approved for clinical use. GLP-1 agonists are available Can You Take a GLP-1

The percentage of adults with GLP-1 prescriptions increased from 0.87% in 2019 to 4.03% in 2024, representing nearly 600% growth over six years ^18

The NHS does not currently recommend GLP-1 receptor agonists for the treatment of Hashimoto's thyroiditis or any thyroid condition in the absence of concurrent type 2 diabetes or obesity meeting specific criteria

When combined with clinical biomarkers (glucose, lipids, baseline GI function), these predispositions can support a more personalized conversation with your provider about optimal dosing and formulation selection

If you want to understand how related treatment timelines compare, the semaglutide opening guide can help you see how BUDs work across GLP-1 medications

This can be especially helpful when youre on-the-go and not able to immediately put the used needle into a medical sharps container